methanocarba adenosine derivatives (NIDDK)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemethanocarba adenosine derivatives (NIDDK)
Drug Alias NameA3 adenosine receptor antagonists and partial agonists (NIDDK)MRS-7292MRS-7232
ClassificationSmall molecules
Mechanisms of ActionAdenosine A3 receptor antagonistsNeuroprotectantsAdenosine A3 receptor partial agonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsNerve DegenerationInflammationCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOregon Health And Science UniversityNational Institutes Of HealthSaint Louis University +[5] 
Active IndicationsN/A
Inactive IndicationsNerve DegenerationInflammationCardiovascular Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A